Adi Eldar Lissai
About Adi Eldar Lissai
Adi Eldar Lissai serves as the Executive Director and Global HEOR Lead at Fulcrum Therapeutics, bringing extensive experience in health economics and outcomes research from previous roles at Sage Therapeutics and Biogen.
Work at Fulcrum
Adi Eldar Lissai serves as the Executive Director, Global HEOR Lead at Fulcrum Therapeutics. He has held this position since 2022, contributing to the company's efforts in health economics and outcomes research. His role involves leading initiatives that demonstrate the value of therapeutic products on a global scale, aligning with Fulcrum's mission to advance innovative treatments.
Previous Experience at Sage Therapeutics
Adi Eldar Lissai worked at Sage Therapeutics in various roles over a span of four years. He began as Associate Director of Health Economics and Outcomes Research from 2017 to 2018, then progressed to Director of HEOR and Value Demonstration from 2018 to 2020, and later served as Senior Director in the same field from 2020 to 2022. His work focused on demonstrating the economic value of Sage's therapeutic products.
Background in Research and Analysis
Adi Eldar Lissai has a strong background in research and analysis. He worked as a Research Assistant at the University of Rochester Cancer Center from 2004 to 2007 and later as a Research Fellow at Finger Lakes Health Systems Agency from 2007 to 2009. Additionally, he served as an Associate at Analysis Group from 2009 to 2014, where he contributed to various analytical projects.
Education and Expertise
Adi Eldar Lissai holds multiple degrees in health-related fields. He earned an MBA in Health Systems Management from Ben-Gurion University between 2000 and 2003. He also obtained an MSc in Medical Statistics and a PhD in Health Services Research & Policy from the University of Rochester School of Medicine and Dentistry, completing his studies from 2003 to 2009. His educational background supports his expertise in health economics and outcomes research.
Experience at Biogen
Adi Eldar Lissai held two positions at Biogen. He served as Associate Director of HEOR, Global Market Access from 2015 to 2017, and as Sr. Manager of Global Market Access from 2014 to 2015. His roles involved strategic planning and implementation of market access initiatives, contributing to Biogen's efforts in the healthcare market.